InsideArbitrage Event Driven Monitor – July 3, 2025
Merger Arbitrage
- THTX: The acquisition of Theratechnologies Inc. (THTX) by CB Biotechnology, LLC, an affiliate of Future Pak, LLC, for a closing value of $254 million. Under the terms of the agreement, CB Biotechnology will acquire all the issued and outstanding common shares of Theratechnologies for $3.01 per share in cash plus one contingent value right (CVR) per share for additional aggregate cash payments of up to $1.19 per CVR if certain milestones are achieved. The cash consideration of $3.01 per share represents a 27.54% premium from the stock’s last close. (Press Release)
- GOGL: CMB.TECH (CMBT) filed Form F-4 for the acquisition of Golden Ocean (GOGL). The companies anticipate that the merger closing will occur in the third quarter of 2025.
- NVEE: NV5 Global (NVEE) filed a definitive proxy statement. The merger is expected to be completed in the second half of 2025.
You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.
Only plus or premium subscribers can access this post. Subscribe today.
